As the ATF6 pathway has been increasingly considered a promising therapeutic target for ischemia-related diseases (Glembotski et al., 2019), we focused the current study on the ATF6 UPR branch in ischemic stroke. The gene discussed is ATF6; the disease is ischemic stroke.